Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind study of HW231019 tablets for acute postoperative pain after abdominal surgery
CTR20263310Phase 2Active
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HW231019 in acute postoperative pain, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Sep 2026; status: active.
02
Drugs
HW231019
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on CTR20263310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263310.